Alterity Therapeutics Limited Working Capital to Net Assets Ratio
Alterity Therapeutics Limited working capital to net assets ratio. Alterity Therapeutics Limited (PBN) has a Working Capital to Net Assets ratio of 99.9% as of December 2025. Working capital of €54.24 Million (current assets of €56.82 Million minus current liabilities of €2.59 Million) is measured against net assets of €54.27 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Alterity Therapeutics Limited tangible book value ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Alterity Therapeutics Limited (2014–2025)
Working capital to net assets ratio of Alterity Therapeutics Limited from 2014 to 2025. This chart shows how Alterity Therapeutics Limited's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of December 2025, the ratio stands at 99.9%, reflecting working capital of €54.24 Million against net assets of €54.27 Million EUR. See Alterity Therapeutics Limited (PBN) liquidity interval to measure how many days the company can operate on defensive assets alone.
Alterity Therapeutics Limited Working Capital to Net Assets Ratio by Year (2014–2025)
Alterity Therapeutics Limited working capital to net assets ratio by year from 2014 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Alterity Therapeutics Limited from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Alterity Therapeutics Limited assets under control.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 99.8% | €42.34 Million | €42.40 Million | €45.87 Million | €3.53 Million | ▲ +0.8 pp |
| 2024 | 99.0% | €13.66 Million | €13.80 Million | €19.04 Million | €5.37 Million | ▼ -0.3 pp |
| 2023 | 99.4% | €22.67 Million | €22.81 Million | €27.05 Million | €4.38 Million | ▼ -0.2 pp |
| 2022 | 99.6% | €35.32 Million | €35.47 Million | €41.14 Million | €5.82 Million | ▼ -0.2 pp |
| 2021 | 99.8% | €30.42 Million | €30.47 Million | €33.49 Million | €3.07 Million | ▲ +0.2 pp |
| 2020 | 99.6% | €7.12 Million | €7.15 Million | €9.84 Million | €2.71 Million | ▼ -0.3 pp |
| 2019 | 99.9% | €16.54 Million | €16.55 Million | €19.86 Million | €3.32 Million | ▲ +0.4 pp |
| 2018 | 99.6% | €16.01 Million | €16.08 Million | €18.65 Million | €2.64 Million | ▼ -0.3 pp |
| 2017 | 99.9% | €23.66 Million | €23.69 Million | €25.25 Million | €1.59 Million | ▲ +0.1 pp |
| 2016 | 99.8% | €31.30 Million | €31.37 Million | €33.66 Million | €2.36 Million | ▲ +0.0 pp |
| 2015 | 99.8% | €39.03 Million | €39.11 Million | €41.74 Million | €2.72 Million | ▲ +0.0 pp |
| 2014 | 99.8% | €37.60 Million | €37.69 Million | €41.55 Million | €3.95 Million | — |